← All trials
NCT02418247
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2013
- Primary completion
- Dec 1, 2017
- Completion date
- Dec 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 556
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- National Cancer Center, KoreaLead sponsor
- National Cancer Center, KoreaReponsible party - principal investigator
- National Cancer Center, KoreaStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.